Wilbanks Smith & Thomas Asset Management’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,749
Closed -$39K 480
2022
Q2
$39K Hold
8,749
﹤0.01% 479
2022
Q1
$66K Hold
8,749
﹤0.01% 497
2021
Q4
$84K Hold
8,749
﹤0.01% 505
2021
Q3
$105K Hold
8,749
﹤0.01% 494
2021
Q2
$131K Sell
8,749
-5,000
-36% -$78.5K 0.01% 481
2021
Q1
$227K Sell
13,749
-1,251
-8% -$23.6K 0.01% 432
2020
Q4
$255K Sell
15,000
-1,234
-8% -$30.4K 0.01% 365
2020
Q3
$603K Buy
16,234
+2,234
+16% +$70K 0.03% 225
2020
Q2
$319K Sell
14,000
-12,500
-47% -$268K 0.02% 296
2020
Q1
$232K Buy
26,500
+13,987
+112% +$214K 0.02% 319
2019
Q4
$184K Buy
12,513
+713
+6% +$9.08K 0.01% 400
2019
Q3
$164K Buy
+11,800
New +$130K 0.01% 404

Other funds holding MESO

Wilbanks Smith & Thomas Asset Management's MESO Position: Q3 2022 in Review

Wilbanks Smith & Thomas Asset Management sold out of Mesoblast (MESO) in Q3 2022, closing a stake of 8,749 shares — an estimated $39K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in MESO in Q3 2019 and held it in 12 quarters. The position peaked at $603K in Q3 2020. 37 funds tracked by Wall St. Rank hold MESO as of Q3 2022.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Mesoblast position as of Q3 2022 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 8,749 Mesoblast shares in Q3 2022, an estimated $39K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Mesoblast in Q3 2019 and held it in 12 quarters.
  • Wilbanks Smith & Thomas Asset Management's Mesoblast position peaked at $603K in Q3 2020.
  • 37 funds tracked by Wall St. Rank held Mesoblast as of Q3 2022.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q3 2022, filed 31 Oct 2022.